购彩中心

题目：Engineering Functional Inorganic-Organic Hybrid Nanomaterials for Biomedical Applications
报告人：沈建良，中国科学院大学温州研究院、温州医科大学眼视光学和视觉科学国家重点实验室研究员
日期：2019年4月8日（星期一） 13:00--15:00
地点：购彩大厅 A楼528会议室 
邀请人：邱惠斌 教授


 报告人简介：



  沈建良， 中国科学院大学温州研究院、温州医科大学眼视光学和视觉科学国家重点实验室研究员。2014 年于中山大学化学学院获得理学博士学位，2012-2017年于康奈尔医学院休斯顿卫理公会研究所从事助理研究员和博士后，2017年加入温州医科大学和中国科学院大学温州研究院。

  目前的研究方向为纳米材料、纳米技术在生物医学领域中的应用。主要将纳米材料用于癌症的成像治疗、微环境代谢机制研究、视网膜新生血管以及其他疾病的诊疗一体化应用。已发表SCI论文40余篇，其中作为第一作者或通讯联系人在Chem. Soc. Rev., Mater. Today, Nano Lett., ACS Nano等高水平学术期刊发表20余篇论文,已 申请和授权专利9项。


摘要：Patients with cancer have limited treatment options, since some carcinoma do not respond to endocrine or targeted therapies. For example, approximately 15% of breast cancers are classified as triple negative, which is a highly aggressive form of breast cancer that lacks expression of the estrogen receptor (ER), progesterone receptor (PR), and Her2/neu. 

Therefore, therapeutic options are limited for the TNBC patients as hormonal and targeted therapies cannot be exploited. Accordingly, there is an urgent need to develop new therapeutic agents against TNBC. 

Here, we explore the role of functional inorganic-organic hybrid systems involved in the siRNA, combination, theranostic therapeutics advancements. Inorganic-organic hybrid platforms as the vectors for drug delivery are promising to give credit to the interdisciplinary cooperation between inorganic, organic, biology and medicine.